Hans‐Georg Rammensee

机构：University of Tübingen · ORCID：0000-0003-1614-2647

发表论文 628 篇 · 总被引 38439 次 · h-index 97

代表论文

• Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial (2025 · Nature Medicine · 被引 56)
• EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation (2026 · Cell · 被引 29)
• Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies (2024 · Science Translational Medicine · 被引 16)
• Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults (2023 · International Journal of Infectious Diseases · 被引 16)
• PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development (2025 · Journal for ImmunoTherapy of Cancer · 被引 9)
• Unveiling conserved HIV-1 open reading frames encoding T cell antigens using ribosome profiling (2025 · Nature Communications · 被引 9)